KMAP BULLETIN: Covered Treatment for Chronic Migraine

Date: 05/29/18

KMAP GENERAL BULLETIN 18120 (PDF)

Effective with dates of service on and after August 1, 2018, providers can bill for onabotulinumtoxinA (Botox®) to treat chronic migraine. Botox will no longer be considered content of service to surgery for chronic migraine.

Note: The effective date of the policy is August 1, 2018. The implementation of State policy by the KanCare managed care organizations (MCOs) may vary from the date noted in the Kansas Medical Assistance Program (KMAP) bulletins. The KanCare Open Claims Resolution Log on the KMAP Bulletins page documents the MCO system status for policy implementation and any associated reprocessing completion dates, once the policy is implemented.

Note: Refer to the CPT® codebook for complete descriptions.

CPT codes, descriptors, and other data only are copyright 2018 American Medical Association (or such other date of publication of CPT). All rights reserved. Applicable FARS/DFARS apply. Information is available on the American Medical Association website.